LON:TSTL Tristel (TSTL) Share Price, News & Analysis GBX 420 +3.00 (+0.72%) As of 12:31 PM Eastern Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsHeadlinesInsider TradesBuy This Stock About Tristel Stock (LON:TSTL) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get Tristel alerts:Sign Up Key Stats Today's Range 416.70▼ 42050-Day Range 350▼ 41752-Week Range 260▼ 572.50Volume251,703 shsAverage Volume101,277 shsMarket Capitalization£200.64 millionP/E Ratio30.74Dividend Yield3.10%Price TargetGBX 400Consensus RatingHold Company Overview Tristel plc is a global infection prevention company focussed on the manufacture and supply of products using its unique proprietary chlorine dioxide (ClO2) chemistry. The Company is a market leader in manual decontamination of medical devices, supplying hospitals under the Tristel brand, and under the Cache brand provides products for sporicidal surface disinfection, in a format which is a sustainable alternative to commonly used pre-wetted plastic wipes. Tristel's head office and manufacturing facility is located in Snailwell, near Cambridge, and operates globally employing approximately 250 people across 14 subsidiaries selling into 40 countries. The Company has been listed on the London Stock Exchange's AIM market since 2005 (AIM: TSTL). For more information about Tristel's product range please visit: https://tristel.com Read More Tristel Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks9th Percentile Overall ScoreTSTL MarketRank™: Tristel scored higher than 9% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion1.0 / 5Analyst RatingHold Consensus RatingTristel has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on no buy ratings, 1 hold rating, and no sell ratings.Amount of Analyst CoverageTristel has only been the subject of 1 research reports in the past 90 days.Read more about Tristel's stock forecast and price target. Earnings and Valuation0.0 / 5Proj. Earnings GrowthN/A Price to Earnings Ratio vs. the MarketThe P/E ratio of Tristel is 30.74, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 26.29.Price to Earnings Ratio vs. SectorThe P/E ratio of Tristel is 30.74, which means that it is trading at a more expensive P/E ratio than the Medical sector average P/E ratio of about 28.58.Price to Book Value per Share RatioTristel has a P/B Ratio of 6.15. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities. Short InterestN/AShort Interest LevelN/A Short InterestThere is no current short interest data available for TSTL. Dividend1.7 / 5Dividend StrengthWeak Dividend LeadershipTristel is a leading dividend payer. It pays a dividend yield of 3.86%, putting its dividend yield in the top 25% of dividend-paying stocks.Dividend GrowthTristel does not have a long track record of dividend growth.Dividend CoverageThe dividend payout ratio of Tristel is 95.14%. Payout ratios above 75% are not desirable because they may not be sustainable.Read more about Tristel's dividend. Sustainability and ESGN/AEnvironmental ScoreN/A Short InterestThere is no current short interest data available for TSTL. News and Social Media2.9 / 5News Sentiment1.16 News SentimentTristel has a news sentiment score of 1.16. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 1.01 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 3 news articles for Tristel this week, compared to 1 article on an average week. Company Ownership0.8 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, Tristel insiders have not sold or bought any company stock.Percentage Held by InsidersOnly 4.89% of the stock of Tristel is held by insiders.Percentage Held by Institutions50.37% of the stock of Tristel is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about Tristel's insider trading history. Receive TSTL Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Tristel and its competitors with MarketBeat's FREE daily newsletter. Email Address TSTL Stock News HeadlinesTristel PLC (TSTL) Stock Price Today - WSJJuly 2, 2025 | wsj.comTristel Plc (LSE:TSTL) Share Price, History, & News - Fool UKJune 27, 2025 | fool.co.ukYour Bank Account Is No Longer SafeWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what the Department of Justice just admitted in court—claiming cash isn't legally your property. What does that mean? It means Washington thinks they can seize, freeze, or drain your accounts—whenever they want.July 14 at 2:00 AM | Priority Gold (Ad)Capital Investment Trends At Tristel (LON:TSTL) Look StrongMay 29, 2025 | finance.yahoo.comUK Stocks Including Tristel That May Be Trading Below Estimated Fair ValueMay 12, 2025 | finance.yahoo.comWith 86% institutional ownership, Tristel plc (LON:TSTL) is a favorite amongst the big gunsMay 5, 2025 | finance.yahoo.comPositive earnings growth hasn't been enough to get Tristel (LON:TSTL) shareholders a favorable return over the last five yearsApril 18, 2025 | finance.yahoo.comAre Tristel plc's (LON:TSTL) Fundamentals Good Enough to Warrant Buying Given The Stock's Recent Weakness?April 1, 2025 | finance.yahoo.comSee More Headlines TSTL Stock Analysis - Frequently Asked Questions How have TSTL shares performed this year? Tristel's stock was trading at GBX 421.60 at the beginning of 2025. Since then, TSTL stock has decreased by 0.4% and is now trading at GBX 420. How were Tristel's earnings last quarter? Tristel plc (LON:TSTL) issued its quarterly earnings data on Monday, February, 24th. The company reported $8.17 earnings per share for the quarter. Tristel had a trailing twelve-month return on equity of 20.43% and a net margin of 15.47%. How do I buy shares of Tristel? Shares of TSTL stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock. What other stocks do shareholders of Tristel own? Based on aggregate information from My MarketBeat watchlists, some other companies that Tristel investors own include Standard Life Aberdeen (SL), Barclays (BARC), BP (BP), Capital One Financial (COF), Lloyds Banking Group (LLOY), Automatic Data Processing (ADP) and Ashtead Group (AHT). Company Calendar Last Earnings2/24/2025Today7/14/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeLON SectorMedical Industry Medical Instruments & Supplies Sub-IndustryN/A Current SymbolLON:TSTL CIKN/A Webwww.tristel.com Phone+44-1638-721500FaxN/AEmployees208Year FoundedN/AProfitability EPS (Trailing Twelve Months)GBX 13.66 Trailing P/E Ratio29.69 Forward P/E Ratio24.90 P/E GrowthN/ANet Income£6.54 million Net Margins15.47% Pretax MarginN/A Return on Equity20.43% Return on Assets9.89% Debt Debt-to-Equity Ratio18.09 Current Ratio3.75 Quick Ratio3.83 Sales & Book Value Annual Sales£42.24 million Price / Sales4.59 Cash FlowGBX 19.36 per share Price / Cash Flow20.96 Book ValueGBX 68.34 per share Price / Book5.94Miscellaneous Outstanding Shares47,770,446Free FloatN/AMarket Cap£193.83 million OptionableNot Optionable Beta0.23 A Beginner's Guide to Investing in CannabisUnlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.Get This Free Report This page (LON:TSTL) was last updated on 7/14/2025 by MarketBeat.com Staff From Our PartnersYour Bank Account Is No Longer SafeWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | Sponsored3..2..1.. AI 2.0 ignition (don’t sleep on this)I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredIs Elon's empire crumbling?The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered ...Brownstone Research | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Something big is brewing in Washington. According to my research, an executive order from President Trump c...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Tristel plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Tristel With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.